Cited by 180Connective tissue disorders researchRNA Research and SplicingGenomics and Rare Diseases

Rare Autosomal Recessive Cardiac Valvular Form of Ehlers-Danlos Syndrome Results from Mutations in the COL1A2 Gene That Activate the Nonsense-Mediated RNA Decay Pathway

Open access
Schwarze, Ulrike, Hata, Ryu-Ichiro, McKusick, Victor A., Shinkai, Hiroshi, Hoyme, H. Eugene, Pyeritz, Reed E., Byers, Peter H.·2004·The American Journal of Human Genetics

Abstract

Splice site mutations in the COL1A2 gene of type I collagen can give rise to forms of Ehlers-Danlos syndrome (EDS) because of partial or complete skipping of exon 6, as well as to mild, moderate, or lethal forms of osteogenesis imperfecta as a consequence of skipping of other exons. We identified three unrelated individuals with a rare recessively inherited form of EDS (characterized by joint hypermobility, skin hyperextensibility, and cardiac valvular defects); in two of them, COL1A2 messenger RNA (mRNA) instability results from compound heterozygosity for splice site mutations in the COL1A2 gene, and, in the third, it results from homozygosity for a nonsense codon. The splice site mutations led to use of cryptic splice donor sites, creation of a downstream premature termination codon, and extremely unstable mRNA. In the wild-type allele, the two introns (IVS11 and IVS24) in which these mutations occurred were usually spliced slowly in relation to their respective immediate upstream introns. In the mutant alleles, the upstream intron was removed, so that exon skipping could not occur. In the context of the mutation in IVS24, computer-generated folding of a short stretch of mRNA surrounding the mutation site demonstrated realignment of the relationships between the donor and acceptor sites that could facilitate use of a cryptic donor site. These findings suggest that the order of intron removal is an important variable in prediction of mutation outcome at splice sites and tha…

Integrity signals

Registry

Crossref · 10.1086/420794

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In cardiac-valvular EDS, SDS PAGE demonstrates complete absence of (pro-)α2 chains of type I (pro)collagen extracted from dermis.

    “SDS PAGE demonstrates complete absence of (pro-) a 2 chains of type I (pro) collagen extracted from dermis [Schwarze et al., 2004; Malfait et al., 2006].”

    From The 2017 international classification of the Ehlers–Danlos syndromes (2017) · cites this paper as Schwarze et al., 2004

  • Seven different mutations have been reported in five independent cardiac-valvular EDS patients.

    “Seven different mutations have been reported in five independent cardiacvalvular EDS patients.”

    From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Schwarze et al., 2004

  • The hallmark of cardiac-valvular EDS is severe cardiac-valvular disease necessitating valve replacement surgery at adult age, in conjunction with variable skin hyperextensibility, atrophic scarring, joint hypermobility, and autosomal recessive inheritance.

    “The hallmark of the condition is the severe cardiac-valvular disease, necessitating valve replacement surgery at adult age, in conjunction with variable skin hyperextensibility, atrophic scarring and joint hypermobility, and autosomal recessive inheritance.”

    From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Schwarze et al., 2004

  • Because of the severe cardiac valve problems in most adult patients, this phenotype was called cardiac-valvular EDS.

    “Because of the severe cardiac valve problems in most of the adult patients, this phenotype was called “cardiac-valvular EDS” [Schwarze et al., 2004].”

    From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Schwarze et al., 2004

  • To date, six patients from five independent families have been reported with cardiac-valvular EDS, with age at diagnosis ranging from 6 to 65 years.

    “To date, six patients from five independent families have been reported (Table S1).Their age at diagnosis ranged from 6 to 65 years [Hata et al., 1988;Kojima et al., 1988;Nicholls et al., 2001;Schwarze et al., 2004;Malfait et al., 2006].”

    From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Schwarze et al., 2004

The citation lists haven’t been fetched yet

References 46 · Cited by 180

Authors
Schwarze, U., Hata, R.-I., McKusick, V. A., Shinkai, H., Hoyme, H. E., Pyeritz, R. E., & Byers, P. H.
Affiliations
  • University of Washington (US)
  • Kanagawa Dental University (JP)
  • Chiba University (JP)
  • Stanford Medicine (US)
  • University of Pennsylvania (US)
Corresponding author
Byers, Peter H.
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2004-05
Volume
74
Issue
5
Pages
917-930
ISSN
0002-9297 (ISSN-L)
OpenAlex
W2131252720
Cited by
180
References
46
Citations by year
2026: 5 · 2025: 8 · 2024: 7 · 2023: 4 · 2022: 10 · 2021: 4 · 2020: 9 · 2019: 16 · 2018: 4 · 2017: 14 · 2016: 6 · 2015: 9 · 2014: 6 · 2013: 17 · 2012: 12
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ar041223-11)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR41223, AR-21557, R01 AR041223, P01AR021557)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords
Ehlers-Danlos syndrome, COL1A2, type I collagen, splice site mutation, nonsense-mediated mRNA decay, mRNA instability, cryptic splice donor site, exon skipping, mRNA folding, compound heterozygosity, homozygous nonsense mutation, valvular heart disease, autosomal recessive inheritance, osteogenesis imperfecta
MeSH terms
Adult, Aged, Base Sequence, Collagen, Ehlers-Danlos Syndrome, Exons, Female, Genes, Recessive, Heart Valve Diseases, Heterozygote, Humans, Introns, Male, Middle Aged, Molecular Sequence Data, Mutation, RNA Splicing, RNA, Messenger, Sequence Homology, Nucleic Acid, Skin, Protein Biosynthesis, Signal Transduction, Codon, Nonsense, RNA Stability, RNA Splice Sites, Collagen Type I

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review